These findings are notable given the importance of surfactant replacement therapy in the newborn intensive care unit and the role of proinflammatory cytokines such as IL-6 and IL-8 in the pathogenesis of chronic respiratory disorders such as bronchopulmonary dysplasia. The gene discussed is CXCL8; the disease is bronchopulmonary dysplasia.